Body
ADVERTISEMENT |
The latest batch of Food and Drug Administration (FDA) inspection letters noting objectionable conditions, aka 483s, has a decidedly international flair: Italy, Japan, and Canada had the pleasure of hosting FDA inspectors in recent months. Three firms were found wanting by the agency in a number of areas.
…
Want to continue?
Log in or create a FREE account.
By logging in you agree to receive communication from Quality Digest.
Privacy Policy.
Comments
A few points
One: Were some Accrediation Bodies less money-minded and more professionally-oriented, the registered Companies would perform better. Two: Were the registered Companies less budget- or tax-concerned, they would perform better. Three: Were FDA less lobbysm-oriented, USA's foreign Suppliers would perform better. Bad events are what they are, there's no excuse; but, at the same time, to prevent bad events, we have to dig deep into their causes: reading of them on newspapers' first page is far from solving the problems. Thank you.
Add new comment